A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients

M. Maftouh; A. Avan; N. Funel; E. Paolicchi; E. Vasile; P. Pacetti; V. Vaccaro; P. Faviana; D. Campani; S. Caponi; A. Mambrini; U. Boggi; M. Cantore; M. Milella; G.J. Peters; M. Reni; E. Giovannetti

doi:https://doi.org/10.2217/pgs.13.225

A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients

M. Maftouh, A. Avan, N. Funel, E. Paolicchi, E. Vasile, P. Pacetti, V. Vaccaro, P. Faviana, D. Campani, S. Caponi, A. Mambrini, U. Boggi, M. Cantore, M. Milella, G.J. Peters, M. Reni, E. Giovannetti

Medical oncology laboratory (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	609-618
Journal	Pharmacogenomics
Volume	15
Issue number	5
DOIs	https://doi.org/10.2217/pgs.13.225
Publication status	Published - 2014

Access to Document

https://doi.org/10.2217/pgs.13.225

Cite this

Maftouh, M., Avan, A., Funel, N., Paolicchi, E., Vasile, E., Pacetti, P., Vaccaro, V., Faviana, P., Campani, D., Caponi, S., Mambrini, A., Boggi, U., Cantore, M., Milella, M., Peters, G. J., Reni, M., & Giovannetti, E. (2014). A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients. Pharmacogenomics, 15(5), 609-618. https://doi.org/10.2217/pgs.13.225

@article{86be2bd9bab946f795afdbd6f97f0733,

title = "A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients",

author = "M. Maftouh and A. Avan and N. Funel and E. Paolicchi and E. Vasile and P. Pacetti and V. Vaccaro and P. Faviana and D. Campani and S. Caponi and A. Mambrini and U. Boggi and M. Cantore and M. Milella and G.J. Peters and M. Reni and E. Giovannetti",

year = "2014",

doi = "https://doi.org/10.2217/pgs.13.225",

language = "Undefined/Unknown",

volume = "15",

pages = "609--618",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "5",

}

Maftouh, M, Avan, A, Funel, N, Paolicchi, E, Vasile, E, Pacetti, P, Vaccaro, V, Faviana, P, Campani, D, Caponi, S, Mambrini, A, Boggi, U, Cantore, M, Milella, M, Peters, GJ, Reni, M & Giovannetti, E 2014, 'A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients', Pharmacogenomics, vol. 15, no. 5, pp. 609-618. https://doi.org/10.2217/pgs.13.225

TY - JOUR

T1 - A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients

AU - Maftouh, M.

AU - Avan, A.

AU - Funel, N.

AU - Paolicchi, E.

AU - Vasile, E.

AU - Pacetti, P.

AU - Vaccaro, V.

AU - Faviana, P.

AU - Campani, D.

AU - Caponi, S.

AU - Mambrini, A.

AU - Boggi, U.

AU - Cantore, M.

AU - Milella, M.

AU - Peters, G.J.

AU - Reni, M.

AU - Giovannetti, E.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.2217/pgs.13.225

DO - https://doi.org/10.2217/pgs.13.225

M3 - Article

C2 - 24798718

SN - 1462-2416

VL - 15

SP - 609

EP - 618

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 5

ER -